Market Overview:

The global surgical sutures market reached a value of US$ 4.54 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 6.49 Billion by 2027, exhibiting at a CAGR of 6.05% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Surgical sutures are medical strands or threads used to ligate blood vessels and sew damaged tissues together after an injury. They are made using natural fibers, such as silk, or synthetic materials like nylon and polyester. They have excellent tensile strength, flexibility, sterility, and knot security. They are widely available in different sizes, types, shapes, and thread materials, based on the surgery requirement. At present, several manufacturers are introducing synthetic monofilament polydioxanone sutures (PDS) that find extensive application in the repairing of soft-tissue wounds and abdominal closures during pediatric cardiac procedures.

Surgical Sutures Market Trends:

Natural healing is a slow process that increases the possibilities of wound contamination and bacterial infection. This, in confluence with the growing number of individuals undergoing surgical procedures, represents one of the major factors positively influencing the demand for surgical sutures. Moreover, the rising prevalence of arthritis, cancer, cardiovascular diseases (CVDs), and other chronic disorders in a significant part of the geriatric population is driving the demand for surgeries across the globe. In addition, the increasing number of fatal road accidents is fueling the adoption of surgical sutures. Apart from this, leading market players are introducing surgical sutures that promote scar-free wound healing and minimize ischemia, excess wound tension, and tissue injury. These sutures are gaining traction in facial and other aesthetic plastic surgery procedures, including mastopexy, brachioplasty, platysmaplasty, reduction mammoplasty, and brow, midface, and lateral neck suspension. This, along with the emerging trend of minimally invasive cosmetic plastic surgeries on account of inflating income levels and the growing consciousness among individuals about physical appearances, is projected to contribute to the growth of the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global surgical sutures market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type, material, application and end user.

Breakup by Type:

• Absorbable Sutures
• Non-Absorbable Sutures
   

Breakup by Material:

• Monofilament
• Multifilament
   

Breakup by Application:

• Cardiovascular Surgeries
• General Surgeries
• Gynecological Surgeries
• Orthopedic Surgeries
• Ophthalmic Surgeries
• Others
   

Breakup by End User:

• Hospitals and Clinics
• Ambulatory Surgical Centers
• Others
   

Breakup by Region:

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
• Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
• Latin America
  • Brazil
  • Mexico
  • Others
• Middle East and Africa
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Advanced Medical Solutions Group plc, B. Braun Melsungen AG, Boston Scientific Corporation, CONMED Corporation, DemeTECH Corporation, Integra LifeSciences, Johnson & Johnson, Medtronic plc, Mellon Medical B.V., Smith & Nephew plc, Stryker Corporation, Teleflex Incorporated and Zimmer Biomet.

Report Coverage: